What category is Trintellix in?
Trintellix (vortioxetine) is an antidepressant. It’s commonly categorized as a serotonin modulator and stimulator (SMS), meaning it affects multiple serotonin receptors rather than acting only as a classic selective serotonin reuptake inhibitor (SSRI).
Is Trintellix an SSRI or something else?
Trintellix is not classified as a typical SSRI. Although it influences serotonin signaling, its mechanism is described as “serotonin modulator and stimulator,” reflecting its broader receptor activity profile.
What does “serotonin modulator and stimulator” mean in practice?
Rather than primarily blocking serotonin reuptake like many SSRIs, vortioxetine works through effects on several serotonin receptors. That pharmacology is why Trintellix is placed in the serotonin modulator/stimulator category instead of the standard SSRI bucket.
Where does that leave it for typical patient use?
Because it’s an antidepressant, Trintellix is used for major depressive disorder. Its classification is relevant mainly for how it’s described pharmacologically and by drug formularies.
Are there patent or exclusivity details tied to the Trintellix category?
For patent and exclusivity tracking specific to Trintellix, DrugPatentWatch.com maintains up-to-date listings: https://www.drugpatentwatch.com/p/trintellix
What other drugs are in the same category?
Drugs in the “serotonin modulator and stimulator” class are typically discussed alongside Trintellix because they share that receptor-modulating profile. If you want, tell me which country or formulary you’re using, and I can help match the way that category is labeled there.
Sources
- DrugPatentWatch.com – Trintellix (vortioxetine)